Bevacizumab (Avastin) slows the growth of new blood vessels that tumors need to supply themselves with nutrients. Will it work better in combination with the new immunotherapy drug MPDL3280A?
Every year, nearly 90,000 women in the United States are diagnosed with a gynecological cancer....
Collaboration between CU Cancer Center and NantBioScience will allow Theodorescu and team to work toward drugs that target Ral protein activation, implicated in nearly a third of all cancers.
Stand Up To Cancer, Pierce Brosnan and Colorado's HERA Women's Cancer Foundation announce new Dream Team to fight ovarian cancer.
At the CU Cancer Center Fall Retreat 2014, Allen S. Lichter, MD, FASCO, CEO of ASCO, points the way toward the future of oncology in 2030
Provider Portrait: Medicine and Music Make a Perfect Match
August 26, 2014 · Comments Off
The Cancer Center’s Anthony Elias, MD, has kept alive his love for music throughout a distinguished career as a clinician and researcher in breast cancer.
University of Colorado’s Online Screening for Rare Lung Cancer Subtypes Opens Door to New Kind of Clinical Trial
August 21, 2014 · Comments Off
CU Cancer Center clinical trial tests the drug ponatinib against lung cancer with mutation in the gene FGFR1. Online questionnaire and free lung cancer tissue testing at CU determines eligibility.
NTRK1: a new oncogene and target in lung cancer
August 21, 2014
NEJM: Crizotinib Effective in Phase 1 Trial Against ROS1 Lung Cancer
September 30, 2014 · No comments
ALK amc cancer fund American Association for Cancer Research andrew thorburn anthony elias antonio jimeno ASCO biomarkers bladder cancer breast cancer cancer cancer grants cancer research colorado cancer stem cells Cancer Survivorship clinical trial colorado cancer benefit colorectal cancer crizotinib CU Cancer Center Dan Theodorescu fred hirsch funding opportunity grant james degregori jennifer richer leukemia lung cancer lung cancer research melanoma microRNA ovarian cancer Pancreatic cancer paul bunn prostate cancer publications rajesh agarwal ross camidge skin cancer Thomas Flaig tim byers university of colorado cancer center university of colorado hospital university of colorado school of medicine wells messersmith
Another fantastic article by our guest blogger Celia Ruiz Tomlinson. fb.me/2HHwiDGD0
CU Cancer Center researcher looks into female sexual health after cancer treatment. “This is a subject that no... fb.me/6OkYVDAdD
Race for the Cure is tomorrow! We hope to see you there! fb.me/6BZ6FkEi0